Recently stock market analysts have updated their consensus ratings on shares of Bacterin International Holdings, Inc. (BONE). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

03/03/2015 – H.C. Wainwright began new coverage on Bacterin International Holdings, Inc. giving the company a “buy” rating. They now have a USD 5 price target on the stock.

09/15/2014 – Bacterin International Holdings, Inc. had its “buy” rating reiterated by analysts at Singular Research. They now have a USD 14 price target on the stock.

07/08/2014 – Bacterin International Holdings, Inc. was upgraded to “neutral” by analysts at Zacks. They now have a USD 0.7 price target on the stock.

01/24/2014 – Bacterin International Holdings, Inc. was downgraded to “sell” by analysts at Noble Financial. They now have a USD 0.3 price target on the stock.

Bacterin International Holdings, Inc. has a 50 day moving average of 3.52 and a 200 day moving average of 3.68.It has a 52-week low of 2.19 and a 52-week high of 4.75.

The share price of the company (BONE) was up +0.00% during the last trading session, with a high of 0.00 and the volume of Bacterin International Holdings, Inc. shares traded was 0.

View other investors thoughts on Bacterin International Holdings, Inc. on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.